Cytori is a stem cell therapeutics and regenerative medicine company publicly traded on NASDAQ as CYTX. Based in San Diego, California, Cytori has offices worldwide, including hubs in Switzerland, Japan, and India. Cytori was established in 2005 from a prior company, MacroPore, and in 2014 focuses on the potential of its breakthrough method of harvesting autologous stem [Page 331]cells for regenerative medicine uses. Its therapeutic division is partnered with key regenerative medicine marketing and storage companies to explore autologous stem cell reimplantation for soft tissue disorders in clinical trials in the United States and for approved indications in the European Union and Japan.